Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Acupuncture and Auditory Evoked Potentials

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2006 by University Medicine Greifswald.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
University Medicine Greifswald
ClinicalTrials.gov Identifier:
NCT00333606
First received: June 3, 2006
Last updated: NA
Last verified: June 2006
History: No changes posted
  Purpose
To investigate whether body acupuncture of acupuncture points specific for hearing influences the auditory avoked potentials in comparison to puncture of non-specific acupuncture points

Condition Intervention Phase
Evoked Potentials
Healthy Volunteers
Procedure: Acupuncture
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind
Primary Purpose: Diagnostic
Official Title: Effects of Acupuncture on the Auditory Evoked Potentials: a Randomized Volunteer Crossover Study

Resource links provided by NLM:


Further study details as provided by University Medicine Greifswald:

Primary Outcome Measures:
  • Latency and amplitude of auditory evoked potentials

Estimated Enrollment: 10
Study Start Date: January 2005
  Eligibility

Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Healthy volunteers aged 20-40 years
  2. Physical status I according to American Society of Anesthesiologists (ASA) classification
  3. No history of nervous or psychiatric disease
  4. Normal audiogram before the study
  5. No chronic consume of analgesics, anticoagulants and/or antiplatelet agents, sedatives or alcohol
  6. No local infection at the site of acupuncture
  7. Volunteers who have given informed consent

Exclusion Criteria:

  1. Pregnant or nursing females.
  2. History of peripheral neuropathy
  3. Abnormal skin conditions (infection, scars, psoriasis, eczema)
  4. Inflamed site of acupuncture within 1 week
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00333606

Locations
Germany
Ernst Moritz Arndt University
Greifswald, Germany, 17475
Sponsors and Collaborators
University Medicine Greifswald
Investigators
Study Chair: Taras I Usichenko, M.D. Ernst Moritz Arndt University
Principal Investigator: Reinhard Schmidt, M.D. Ernst Moritz Arndt University
  More Information

ClinicalTrials.gov Identifier: NCT00333606     History of Changes
Other Study ID Numbers: III UV 12/06 
Study First Received: June 3, 2006
Last Updated: June 3, 2006
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

ClinicalTrials.gov processed this record on December 05, 2016